QuickSee Plus for Refractive Errors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new device called QuickSee Plus to improve vision correction for people with refractive errors, such as nearsightedness or farsightedness. Participants will try two pairs of glasses: one made using an automated method and the other using a traditional method, to determine their preference. The goal is to identify which method provides better vision and comfort. Ideal participants have had an eye exam at the NECO Center for Eye Care and currently wear glasses for vision correction. As an unphased trial, this study allows participants to explore innovative vision correction methods and contribute to advancements in eye care.
Will I have to stop taking my current medications?
The trial excludes people who are taking systemic drugs, so you would need to stop taking those medications to participate.
What prior data suggests that the QuickSee Plus refractor is safe for evaluating refractive errors?
A previous study compared the QuickSee wavefront autorefractor, a device similar to QuickSee Plus, to traditional eye exams. The study found QuickSee to be generally safe and well-tolerated, with no serious side effects reported. This device accurately measures eye prescriptions, especially in areas with limited access to eye care.
The QuickSee Plus operates similarly, providing automated eye exam results. It has been used to check for vision changes and to help prescribe glasses, with no reports of harmful effects.
Since this trial is not in a specific phase, it likely evaluates user experiences rather than testing for new risks. This suggests that QuickSee Plus is expected to be safe for participants.12345Why are researchers excited about this trial?
Researchers are excited about QuickSee Plus for refractive errors because it offers a fresh approach to vision correction. Unlike traditional methods, which typically rely on either automated or subjective refraction to prescribe eyeglasses, QuickSee Plus combines both techniques in a unique sequence. This dual approach aims to enhance accuracy in prescriptions and improve overall visual outcomes for patients. By potentially streamlining the process and reducing the margin of error, QuickSee Plus could lead to more personalized and effective vision correction solutions.
What evidence suggests that the QuickSee Plus refractor is effective for refractive errors?
This trial will compare the effectiveness of Automated Refraction (AR) Eyeglasses and Subjective Refraction (SR) Eyeglasses using the QuickSee Plus device. Studies have shown that the QuickSee Plus device effectively detects common eye conditions like nearsightedness, farsightedness, and astigmatism. Research indicates that QuickSee provides measurements for glasses prescriptions similar to those from traditional eye exams. In one study, QuickSee tested children and successfully completed tests 95.7% of the time. The device is known for its accuracy, even in areas with limited access to eye care. Overall, QuickSee Plus offers a reliable way to determine eye prescriptions.36789
Are You a Good Fit for This Trial?
This trial is for individuals aged 18-65 who are currently being treated for refractive errors (vision problems) and are interested in finding the most comfortable eyeglass prescription. Participants will be evaluated at the New England College of Optometry in Boston, MA.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to receive eyeglasses from either automated or subjective refraction first, followed by the alternate method
Follow-up
Participants are monitored for patient preference after wearing each pair of glasses
What Are the Treatments Tested in This Trial?
Interventions
- QuickSee Plus
Find a Clinic Near You
Who Is Running the Clinical Trial?
PlenOptika, Inc.
Lead Sponsor
New England College of Optometry
Collaborator
National Eye Institute (NEI)
Collaborator